ESSEX INVESTMENT MANAGEMENT CO LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 40 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$2,458,000
+143.1%
80,138
+112.3%
0.29%
+127.6%
Q2 2018$1,011,00037,7420.13%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders